Altre lingue DiaSorin S.p.A.

Azioni

DIA

IT0003492391

Fornitura medica

Mercato chiuso - Borsa Italiana Altri mercati azionari 17:45:00 06/02/2026			Variaz. 5gg	Var. 1 gen.
73,48 ^EUR	-1,47%		+1,80%	+7,08%

06/02	DiaSorin ha acquistato azioni proprie per oltre EUR10 milioni	AN
04/02	Morning Meeting: Anthropic sta creando scompiglio nel settore del software

Altre lingue

03/02	Diasorin submits Liaison NES Group A Strep molecular test to the U.S. FDA for 510(k) clearance and CLIA waiver
03/02	DiaSorin S p A : submits LIAISON NES Group A Strep molecular test to the U.S. FDA for 510(k) Clearance and CLIA Waiver
30/01	DIARY - Italy to March 31
29/01	Diasorin receives approval for HDV laboratory test in the U.S.
29/01	DiaSorin S p A : has been granted De novo authorization in the U.S. for the First Fully Automated Laboratory Test for Hepatitis Delta Virus (HDV) on the LIAISON XL
29/01	Italy - Factors to watch on January 29
28/01	DIARY - Italy to March 31
26/01	DiaSorin S p A : signs exclusive distribution agreement for the LIAISON NES® molecular point‑of‑care platform and the Flu A/B, RSV & Covid‑19 panel
26/01	U.S. Futures Flat, European Stocks Mixed
26/01	Nexi's Board Names New Group Finance Chief
26/01	Italy - Factors to watch on January 26
23/01	DiaSorin appoints Alberto Donati as group CFO
23/01	DIARY - Italy to March 31
23/01	DiaSorin S p A : Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer.
07/01	Avis d'analystes du jour : de nouveaux avis positifs sur Société Générale, Danone et ArcelorMittal
07/01	Les records continuent à tomber en bourse
30/12	AlphaValue/Baader Europe Cuts Diasorin Price Target, Forecasts Amid Challenges to Near-term Earnings
30/12	DiaSorin trims outlook amid market headwinds
30/12	DiaSorin S p A : receives FDA 510(k) clearance and CLIA-waiver for its first assay, the 4-Plex Respiratory Panel, on the LIAISON NES Molecular Diagnostics platform
28/12	DiaSorin S p A : receives FDA 510(k) clearance and CLIA-waiver for its first assay, the 4-Plex Respiratory Panel, on the LIASON NES Molecular Diagnostics platform
23/12	Italy - Factors to watch on December 23
22/12	Diasorin board proposes buyback up to EUR 250 mln
22/12	ÜBERBLICK/Anstehende Indexänderungen zum 22. Dezember
19/12	ÜBERBLICK/Anstehende Indexänderungen zum 22. Dezember
18/12	ÜBERBLICK/Anstehende Indexänderungen zum 22. Dezember

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Filtri

Ultime notizie

DiaSorin riduce le previsioni a causa delle difficoltà di mercato

30 dicembre 2025 alle 14:02